CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +786 | $63.55 | $50K | 13,722 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −786 | $163.49 | $129K | 12,936 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +1,600 | $63.55 | $102K | 14,536 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −1,600 | $164.84 | $264K | 12,936 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +200 | $63.55 | $13K | 13,136 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −200 | $166.04 | $33K | 12,936 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +300 | $63.55 | $19K | 13,236 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −300 | $167.85 | $50K | 12,936 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +1,133 | $63.55 | $72K | 14,069 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −1,133 | $169.10 | $192K | 12,936 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +210 | $63.55 | $13K | 13,146 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −210 | $169.75 | $36K | 12,936 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +134 | $63.55 | $9K | 13,070 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −134 | $171.66 | $23K | 12,936 |
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 35,000 | ||
| 2024-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 30,000 | ||
| 2024-02-28 | Krishnan Suma President, R&D | Option exercise | +7,500 | 1,579,353 | ||
| 2024-02-28 | Krishnan Suma President, R&D | Shares withheld for taxes | −3,471 | $163.08 | $566K | 1,575,882 |
| 2024-02-28 | Krishnan Suma President, R&D | Option exercise | +12,500 | 1,643,047 | ||
| 2024-02-28 | Krishnan Suma President, R&D | Shares withheld for taxes | −5,785 | $163.08 | $943K | 1,637,262 |
Page 25 of 42 · 828 trades